
UK lifts sanctions on Syria, says country deserves chance to rebuild economy
The UK government has said it is lifting sanctions against a dozen Syrian entities, including government departments and media outlets, to help the country rebuild after President Bashar al-Assad was toppled in a lightning rebel offensive in December.
The UK had put the sanctions in place against those who supported Assad's repressive rule, helped violently suppress civilians and spread misinformation.
"The Syrian people deserve the opportunity to rebuild their country and economy and a stable Syria is in the UK's national interest," Hamish Falconer, minister for the Middle East, said in a statement.
Syria's new leaders have struggled to begin rebuilding the country's decimated economy and infrastructure after nearly 14 years of civil war.
The new authorities in Damascus have made a push for harsh sanctions imposed by western countries on Assad's government to be lifted, with limited success.
Syrians commemorate the seventh anniversary of a chemical attack in the town of Douma, 7 April, 2025
AP Photo
Financial sanctions and asset freezes were lifted on several government agencies, including the ministries of interior and defence, the UK Foreign Office said.
Sanctions were also dropped against the General Organization of Radio and TV, a state-run agency that allegedly spread propaganda for Assad and incited violence against civilians.
The Foreign Office said it also lifted sanctions against Al Watan, a newspaper, Cham Press TV, and Sama TV, for spreading misinformation.
Sanctions imposed against al-Assad and associates remain in place and legislation was amended to allow the former leader and others to be held accountable for atrocities committed against Syrians.
In March, the UK dropped sanctions against two dozen Syrian businesses, mostly banks and oil companies.
The Trump administration has yet to formally recognise the new Syrian government led by President Ahmad al-Sharaa, an Islamist former insurgent who led the offensive that ousted al-Assad.
Syria's interim President Ahmad al-Sharaa during a press conference in Ankara, 4 February, 2025
AP Photo
The militant group al-Sharaa led, Hayat Tahrir al-Sham (HTS), remains a US-designated terrorist organisation and the sanctions imposed on Damascus under al-Assad remain in place.
However, Washington has eased some restrictions.
In January, the US Treasury issued a general licence, lasting six months, that authorises certain transactions with the Syrian government, including some energy sales and incidental transactions.
The European Union, meanwhile, has begun to ease some energy and transport sanctions and banking restrictions against Syria, suspending measures targeting oil, gas and electricity as well as transport, including the aviation sector.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Euronews
13 hours ago
- Euronews
EU-US trade deal leaves future of pharma tariffs uncertain
The current status of tariffs on pharmaceuticals between the EU and the US remains uncertain, despite the announcement on Sunday of a new transatlantic trade agreement. The situation is particularly sensitive given the mutual dependency in the sector: the US imports large volumes of critical pharmaceuticals from the EU, while EU-based pharmaceutical companies—especially in Ireland and Denmark—rely heavily on access to the American market. Although the new trade agreement will officially enter into force on 1 August, pharmaceuticals will not be subject to a 15% tariff which will be slapped on most goods imported from the European Union to the United States. This does not mean that there won't be tariffs at all on pharmaceuticals, as the US is still conducting an investigation into imported pharmaceuticals to assess whether they threaten US national security. For this reason, pharmaceuticals were technically excluded from yesterday's formal agreement, several EU sources confirm, as the US could not commit to any decision on tariff changes, which will only come after the conclusion of that process. However, if tariffs are introduced following the investigation, the EU expects the US—under President Trump—to honour the informal understanding reached during negotiations. This includes a cap of 15% on tariffs, which the EU considers "all-inclusive", meaning it should apply even to products still under investigation, such as pharmaceuticals and semiconductors. 'I believe that this commitment will be honoured and respected in this case as well,' said EU Trade Commissioner Maroš Šefčovič during a press briefing following the deal. So, what happens after 1 August? In the short term, nothing will change. Despite earlier reports suggesting the US would impose a 15% tariff on pharmaceuticals too in line with most EU goods, that is not expected to happen immediately. 'There will be no tariffs on pharmaceuticals this Friday,' clarified a senior EU official who participated in the negotiations with President Trump in Scotland. Most pharmaceutical products traded between the EU and the US currently benefit from a 0% tariff rate under the Most-Favoured Nation (MFN) framework. This is consistent with prior US-EU trade arrangements and World Trade Organization (WTO) commitments. As a result, EU pharmaceutical exports have faced no tariff barriers when entering the US market—a condition that remained unchanged even after Trump's so-called "Liberation Day", when he announced imposing blanket tariffs on goods. Uncertain outcome of the US investigation But tariffs on pharmaceuticals are expected to come at one point. The key uncertainty revolves around the ongoing Section 232 investigation being conducted by the Trump administration. This probe, authorised under the Trade Expansion Act of 1962, is intended to assess whether imports of pharmaceuticals (and other products as well such as semiconductors) threaten US national security. The investigation's conclusions could lead to unilateral actions by the US, including higher tariffs or import restrictions, independent of the broader trade deal struck yesterday. '[During the talks] President Trump wanted to make clear that they still have full freedom to conclude the 232 investigations and to choose any policy measures as a result,' said another EU negotiator. While EU officials cannot predict the outcome of the US investigation, they believe it is nearing completion. 'These are two investigations—pharmaceuticals and semiconductors—that are pretty close to conclusion,' an official noted. If the US does impose tariffs following the investigation, the EU expects these to be capped at 15% for both sectors, in line with the political understanding reached during the trade talks. EU's bet on pharma tariffs The EU's strategy is clear: even though Trump could not legally commit yesterday to tariffs on pharmaceuticals while the investigation is ongoing, the EU insisted on a 15% ceiling across all sectors, with no exclusions for pharmaceuticals. A senior EU official added that this understanding is backed by a broader political commitment, including planned investments by pharmaceutical companies in the US and pressure from the industry on both sides of the Atlantic to collaborate more closely. 'There is a clear understanding that investments, supply chain integration, and joint R&D efforts should all fall under the special 15% regime,' the official explained. Still, the EU acknowledges that this is not yet a legally binding commitment. 'Is this a legal commitment? No, not at this stage. That would have to come through an executive order once the US concludes its investigation,' the source continued. For now, both pharmaceutical and semiconductor products remain at zero-duty 0rates. No changes will occur on 1 August, but that could change once the US finalises its Section 232 investigation.


Euronews
13 hours ago
- Euronews
Oil prices rise on EU-US trade deal and Trump comments on Ukraine
Oil prices rose on Monday afternoon in Europe after US President Donald Trump said he would reduce the deadline for Russian President Vladimir Putin to reach a peace deal with Ukraine. WTI was up around 2.2% at $66.50 a barrel, while Brent crude oil was up around 2% at $69.80, as of 15.00 CEST. Trump issued the 50-day timeline to Putin in July, claiming that he would hit Russia with a 100% tariff if Moscow didn't end the war in Ukraine. 'I'm disappointed in President Putin, very disappointed in him. So we're going to have to look and I'm going to reduce that 50 days that I gave him to a lesser number,' Trump told reporters in Scotland on Monday. 'I think I already know the answer, what's going to happen,' Trump said. The president was preparing to meet UK Prime Minister Keir Starmer. Oil prices had risen earlier in the day on Monday as investors reacted to news of a EU-US trade deal, announced on Sunday. Among other provisions, the EU agreed to buy $750 billion of US energy products, including oil, LNG, and nuclear energy over three years. The deal means that the EU will face a 15% tariff on most of its goods when Trump's tariff deadline ends on 1 August, rather than a threatened 30% rate. European stock markets also jumped during Monday morning trading on the news, before settling in the afternoon. Trump's tariff threats have previously deflated oil prices this year as investors predicted that a potential economic slowdown could affect demand for oil. Geopolitical risk, on the other hand, has stoked prices in cases where investors have expected threats to supply. US attacks on Iran's nuclear facilities, for example, prompted a spike in oil prices in June. An OPEC+ committee meeting is taking place on Monday, where participants will decide on production policy for September. Both the International Energy Agency and the US Energy Information Administration expect a strong oil surplus next year, with supply outpacing demand. After securing a deal with the EU, Washington has now set its sights on negotiations with China. US Treasury Secretary Scott Bessent and US Trade Representative Jamieson Greer are meeting with Chinese officials, including Chinese Vice Premier He Lifeng, on Monday in Stockholm. China and the US agreed to temporarily lower reciprocal tariffs during a 90-day truce period, set to expire on 12 August. There are hopes that the two nations will be able to extend the grace period, with China currently taxing US goods at 10% and the US taxing Chinese goods at 30%.

LeMonde
15 hours ago
- LeMonde
French prosecutors seek new Assad arrest warrant
French prosecutors said Monday, July 28, they have requested a new arrest warrant against Syria's former president Bashar al-Assad over a deadly 2013 chemical attack after a previous one was cancelled. It is now up to investigating magistrates to decide whether to issue the new warrant. French investigators have since 2021 been looking into a suspected Syrian government sarin gas attack that killed more than 1,000 people, according to US intelligence, on August 4-5, 2013, in the areas of Adra and Douma outside Damascus. The Court of Cassation, France's highest court, on Friday ruled there were no exceptions to presidential immunity, even for alleged war crimes and crimes against humanity, annulling a French warrant against Assad issued in 2023 when he was still leader. It however added that, as Assad, who was toppled in December, was no longer president, new warrants could be issued and the French investigation could continue. The National Anti-Terror Prosecutor's Office (PNAT) said they on Friday requested "the issuing and international dissemination of an arrest warrant against Bashar al-Assad for alleged complicity in crimes against humanity and complicity in war crimes" in the chemical attack case. Assad and his family fled to Russia, according to Russian authorities, after Islamist-led fighters seized power on December 8. Another French warrant is already out for Assad's arrest, issued in January for suspected complicity in war crimes for a bombing in the Syrian city of Deraa in 2017 that killed a French-Syrian civilian.